These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11493771)

  • 1. Allogeneic stem cell transplantation for renal cell carcinoma.
    Childs R; Drachenberg D
    Curr Opin Urol; 2001 Sep; 11(5):495-502. PubMed ID: 11493771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of renal cell carcinoma as a target for allogeneic based cancer immunotherapy.
    Childs RW; Igarashi T
    Exp Nephrol; 2002; 10(3):227-34. PubMed ID: 12053124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic stem-cell transplantation in renal-cell carcinoma.
    Hayes-Lattin BM; Maziarz RT; Beer TM
    Curr Oncol Rep; 2001 Sep; 3(5):433-7. PubMed ID: 11489245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.
    Takahashi Y; Childs RW
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6353S-9S. PubMed ID: 15448030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in allogeneic stem cell transplantation: directing graft-versus-leukemia at solid tumors.
    Childs R; Srinivasan R
    Cancer J; 2002; 8(1):2-11. PubMed ID: 11895199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.
    Arya M; Chao D; Patel HR
    Nat Clin Pract Oncol; 2004 Nov; 1(1):32-8. PubMed ID: 16264797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation as immunotherapy for nonhematological cancers.
    Srinivasan R; Barrett J; Childs R
    Semin Oncol; 2004 Feb; 31(1):47-55. PubMed ID: 14970937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
    Childs R; Chernoff A; Contentin N; Bahceci E; Schrump D; Leitman S; Read EJ; Tisdale J; Dunbar C; Linehan WM; Young NS; Barrett AJ
    N Engl J Med; 2000 Sep; 343(11):750-8. PubMed ID: 10984562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma.
    Childs RW
    Crit Rev Immunol; 2001; 21(1-3):191-203. PubMed ID: 11642604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoetic stem cell transplantation for cytokine refractory renal cell carcinoma.
    Drachenberg D; Childs RW
    Cancer Treat Res; 2003; 116():213-26. PubMed ID: 14650835
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation as immunotherapy for renal cell carcinoma: from immune enhancement to immune replacement.
    Drachenberg D; Childs RW
    Urol Clin North Am; 2003 Aug; 30(3):611-22. PubMed ID: 12953759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.
    Harlin H; Artz AS; Mahowald M; Rini BI; Zimmerman T; Vogelzang NJ; Gajewski TF
    Bone Marrow Transplant; 2004 Mar; 33(5):491-7. PubMed ID: 14716341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation for the treatment of advanced solid tumors.
    Bregni M; Bernardi M; Ciceri F; Peccatori J
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):95-108. PubMed ID: 15378271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
    Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study.
    Ishiyama K; Takami A; Suzuki S; Konaka H; Namiki M; Ooi A; Nakao S
    Jpn J Clin Oncol; 2009 Dec; 39(12):807-12. PubMed ID: 19770130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic cell transplantation as immunotherapy for solid tumors: current status and future directions.
    Lundqvist A; Childs R
    J Immunother; 2005; 28(4):281-8. PubMed ID: 16000944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation for renal cell carcinoma.
    Bregni M; Herr W; Blaise D;
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):901-11. PubMed ID: 21707287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for renal cell cancer.
    Yang JC; Childs R
    J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].
    Cheng YC; Ueno NT
    Nihon Rinsho; 2003 Sep; 61(9):1619-34. PubMed ID: 14515734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.